CellAct Pharma's Topoisomerase Inhibitor Demonstrates Success in Phase I Study Involving Adults With Heavily Pretreated Solid Tumors
11/12/2012 10:22:29 AM
More...
|
CellAct Pharma Advances Phase I Clinical Trial of Topoisomerase Inhibitor in Cancer
10/16/2009 10:21:43 AM
More...
|